Research by Oflazoglu and colleagues now suggests that CD27–CD70 blockade could be a promising therapeutic strategy for autoimmune and autoinflammatory disorders. In addition, because the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback